Lapsi Health is developing the new generation of digital biomarkers based on auscultatory sound. The data used as a biomarker has to be quantifiable and objective and the company’s novel technology greatly enhances its usage in medicine, relating it to the health-disease process for prognostic, diagnostic and therapeutic purposes.

 

  • Founding year:
  • 2022
  • Development phase:
  • Prototype/beta testing
  • Funding stage:
  • Pre-seed/Seed
  • Website:
  • Contact person info:
  • info(at)lapsihealth.com
  • Team members:
  • 6